XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Financial Position
$ in Thousands
Mar. 31, 2024
EUR (€)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
EUR (€)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
EUR (€)
Dec. 31, 2022
USD ($)
Current            
Cash   $ 4,156   $ 4,350   $ 8,935
Restricted cash   35   35   0
Trade and amounts receivable, net of allowance   3,218   3,950   5,259
Loans receivable and advances       0   271
Prepaid expenses and other current assets   1,049   1,368   805
Indemnification receivables   4,063   3,153   3,429
Inventory   9,246   8,508   8,747
Current assets held for sale       0   3,709
Total current assets   21,767   21,364   31,155
Non-current            
Property, plant and equipment   786   847   1,218
Operating lease right of use assets   710   389   2,118
Intangible assets   908   946   17,739
Goodwill       0   23,372
Investments       0   730
Other Assets   103   80   263
Noncurrent assets held for sale       0   4,392
Total assets   24,274   23,626   80,987
Current            
Trade payables   5,005   5,111   7,831
Contingencies   6,591   5,500   5,044
Current portion of debt   3,078   1,931   1,086
Current portion of operating lease liability   803   799   1,116
Current portion of contingent purchase considerations   1,702   1,095   0
Other accrued liabilities   2,140   1,844   1,760
Current liabilities held for sale       0   610
Total current liabilities   19,319   16,280   17,447
Non-current            
Non-current operating lease liability   1,817   942   1,561
Deferred tax       0   1,712
Contingent purchase considerations       0   3,547
Noncurrent liabilities held for sale       0   308
Total liabilities   21,136   17,222   24,575
SHAREHOLDERS' EQUITY            
Share capital, no par value, unlimited authorized   0   0   0
Additional paid-in capital   148,871   149,093   150,420
Accumulated other comprehensive loss   (113)   (140)   (2,732)
Accumulated deficit   (145,620)   (142,549)   (90,865)
Total Flora Growth Corp. shareholders' equity       6,404   56,823
Non-controlling interest in subsidiaries       0   (411)
Total shareholders' equity   3,138   6,404   56,412
Total liabilities and shareholders' equity   $ 24,274   $ 23,626   $ 80,987
TruHC Pharma GmbH [Member]            
Current            
Cash | € € 13,899   € 13,588   € 15,281  
Trade and amounts receivable, net of allowance | € 21,182   18,894   18,399  
Prepaid expenses and other current assets | € 20,347   20,347   20,347  
Total current assets | € 55,428   52,829   54,027  
Non-current            
Property, plant and equipment | € 91,095   94,837   104,775  
Operating lease right of use assets | € 459,515   478,399   553,936  
Total assets | € 606,038   626,065   712,738  
Current            
Trade payables | € 47,522   34,711   27,341  
Current portion of operating lease liability | € 64,477   63,083   57,805  
Other accrued liabilities | € 11,620   11,520   2,720  
Total current liabilities | € 123,619   109,314   87,866  
Non-current            
Non-current portion of debt | € 720,730   645,339   318,590  
Non-current operating lease liability | € 430,930   447,581   510,664  
Total liabilities | € 1,275,279   1,202,234   917,120  
SHAREHOLDERS' EQUITY            
Share capital, no par value, unlimited authorized | € 25,000   12,500   12,500  
Accumulated deficit | € (694,241)   (588,669)   (216,882)  
Total shareholders' equity | € (669,241)   (576,169)   (204,382)  
Total liabilities and shareholders' equity | € € 606,038   € 626,065   € 712,738